Sort
82,697 grants matching “vaccine development”
Adjuvant Development Program
$1,673,631Gary A Van Nest · Dynavax Technologies Corporation · N01 · FY2009 · AI
CARIBBEAN PRIMATE RESEARCH CENTER PROGRAM
$1,673,346Edmundo Nelson Kraiselburd · University Of Puerto Rico Med Sciences · P40 · FY2008 · RR
Recombinant Subunit West Nile Virus Vaccine Development
$1,673,045L2 Diagnostics, Llc · U01 · FY2005 · AI
HIV VACCINE CLINICAL TRIAL UNIT AT SAINT LOUIS UNIVER
$1,672,971Saint Louis University · U01 · FY2002 · AI
Malaria Vaccine: CSP-rEPA
$1,672,898Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
IND-enabling Preclinical Studies on Anti-Tau AD Vaccine for Phase 1 Trial
$1,672,856Michael G Agadjanyan · Institute For Molecular Medicine · U01 · FY2021 · AG
Moffitt Skin Cancer SPORE
$1,672,774Jeffrey S Weber · H. Lee Moffitt Cancer Ctr & Res Inst · P50 · FY2013 · CA
SPORE in Cervical Cancer
$1,672,035T.-C. Wu · Johns Hopkins University · P50 · FY2023 · CA
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) - DOC
$1,671,972Donald Robert Harris · Westat, Inc. · U01 · FY2016 · HD
B Cell Epitope Discovery and Mechanisms of Antibody Protection: Responses to Dengue 4, Powassan, Chikungunya, and Venezuelan Equine Encephalitis Viruses
$1,671,692Daved Fremont · Washington University · N01 · FY2023 · AI
Host Defense Against HIV-related Pulmonary Infections
$1,671,641Judd E Shellito · Lsu Health Sciences Center · P01 · FY2013 · HL
Miami Womens Interagency HIV Study WIHS
$1,671,534Margaret A Fischl · University Of Miami School Of Medicine · U01 · FY2017 · AI
Development Of New Approaches To Vaccines Against TBEV and West Nile Virus
$1,671,396Alexander Pletnev · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Modeling Early Immunity to Human Influenza Infection
$1,671,089Stuart C. Sealfon · Icahn School Of Medicine At Mount Sinai · U19 · FY2017 · AI
Modeling Early Immunity to Human Influenza Infection
$1,671,089Stuart C. Sealfon · Icahn School Of Medicine At Mount Sinai · U19 · FY2019 · AI
Advanced Development of Vaccines for Infectious Diseases
$1,671,005Neal Van Hoeven · Access To Advanced Health Institute · N01 · FY2023 · AI
Environmental/genetic Risk Factors and Pathogenesis of Autoimmune Disease
$1,670,947Frederick Miller · National Institute Of Environmental Health Sciences · ZIA · FY2012 · ES
Activation of Plasmacytoid Dendritic Cells (pDCs) to Induce Antitumor Activity
$1,670,604Patrick Hwu · University Of Tx Md Anderson Can Ctr · P01 · FY2008 · CA
Origin and maturation of protective memory B cell responses against pathogenic viruses in natural infections and upon vaccination.
$1,670,518Mattia Bonsignori · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Preclinical Studies of Vaccines for Pandemic Influenza
$1,670,025Kanta Subbarao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Exploring the impact of inflammaging on immune function during M. tb infection
$1,669,920Joanne Turner · Texas Biomedical Research Institute · P01 · FY2019 · AG
Novel Approaches to Stem Cell Transplantation
$1,669,869Nelson J. Chao · Duke University · P01 · FY2013 · CA
SPORE in Cervical Cancer
$1,669,823T.-C. Wu · Johns Hopkins University · P50 · FY2022 · CA
Comparison of High vs. Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant Recipients
$1,669,617Natasha Bassam Halasa · Vanderbilt University Medical Center · U01 · FY2024 · AI
Role of Viral Reservoirs in the Pathogenesis of HIV Disease
$1,668,909Tae-Wook Chun · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI